Real-world treatment patterns, survival outcomes, and health care resource utilization for locally advanced or metastatic urothelial carcinoma in Spain
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Real-world treatment patterns, survival outcomes, and health care resource utilization for locally advanced or metastatic urothelial carcinoma in Spain ; day:4 ; month:10 ; year:2024 ; pages:1-9
Clinical and translational oncology ; (4.10.2024), 1-9
- Creator
-
Puente, Javier
Pinto, Alvaro
Mendez-Vidal, Maria José
García del Muro, Xavier
Maroto, Pablo
Vazquez, Sergio
Luque-Caro, Raquel
Anido, Urbano
Strunz-McKendry, Torsten
Upadhyay, Anil
Montes, Jose
Ortiz Nuñez, Aurora
González Portela, Judit
Castellano, Daniel
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12094-024-03734-8
- URN
-
urn:nbn:de:101:1-2412202118425.083959834954
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Puente, Javier
- Pinto, Alvaro
- Mendez-Vidal, Maria José
- García del Muro, Xavier
- Maroto, Pablo
- Vazquez, Sergio
- Luque-Caro, Raquel
- Anido, Urbano
- Strunz-McKendry, Torsten
- Upadhyay, Anil
- Montes, Jose
- Ortiz Nuñez, Aurora
- González Portela, Judit
- Castellano, Daniel
- SpringerLink (Online service)
Other Objects (12)
HER2-targeting antibody–drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study
Exposure–response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma
Comparison between urothelial and non-urothelial urethral cancer
Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study
Impact on healthcare resource utilization of multiple sclerosis in Spain
A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma
Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional Thresholding
Migraine treatment: quo vadis? Real-world data study (2015–2022) in Spain
Management of Locally Advanced Unresectable or Metastatic Urothelial Carcinoma: Expert Opinion from an Indian Panel via Delphi Consensus Method
Prediction of locally advanced urothelial carcinoma of the bladder using clinical parameters before radical cystectomy : a prospective multicenter study
A Podcast on Platinum Eligibility and Treatment Sequencing in Platinum-Eligible Patients with Locally Advanced or Metastatic Urothelial Carcinoma
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study
HER2-targeting antibody–drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study
Exposure–response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma
Comparison between urothelial and non-urothelial urethral cancer
Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study
Impact on healthcare resource utilization of multiple sclerosis in Spain
A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma
Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional Thresholding
Migraine treatment: quo vadis? Real-world data study (2015–2022) in Spain
Management of Locally Advanced Unresectable or Metastatic Urothelial Carcinoma: Expert Opinion from an Indian Panel via Delphi Consensus Method
Prediction of locally advanced urothelial carcinoma of the bladder using clinical parameters before radical cystectomy : a prospective multicenter study
A Podcast on Platinum Eligibility and Treatment Sequencing in Platinum-Eligible Patients with Locally Advanced or Metastatic Urothelial Carcinoma
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study
HER2-targeting antibody–drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study
Exposure–response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma
Comparison between urothelial and non-urothelial urethral cancer
Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study
Impact on healthcare resource utilization of multiple sclerosis in Spain
A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma
Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional Thresholding
Migraine treatment: quo vadis? Real-world data study (2015–2022) in Spain
Management of Locally Advanced Unresectable or Metastatic Urothelial Carcinoma: Expert Opinion from an Indian Panel via Delphi Consensus Method
Prediction of locally advanced urothelial carcinoma of the bladder using clinical parameters before radical cystectomy : a prospective multicenter study
A Podcast on Platinum Eligibility and Treatment Sequencing in Platinum-Eligible Patients with Locally Advanced or Metastatic Urothelial Carcinoma